ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 1185

$729K Total Retail Price of All Prescriptions

Rank: 112 out of 1185

534 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,084 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
OMEPRAZOLE 429 387 1 6
SIMVASTATIN 367 305 2 5
ZOLPIDEM TARTRATE 346 284 3 15
LOSARTAN-HYDROCHLOROTHIAZIDE 311 277 4 36
ATORVASTATIN CALCIUM 299 236 5 11
HYDROCODONE-ACETAMINOPHEN 296 252 S3 6 2
LISINOPRIL 285 244 7 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 273 219 8 14
LEVOTHYROXINE SODIUM 273 216 8 3
METOPROLOL TARTRATE 245 204 10 10
AMLODIPINE BESYLATE 238 216 11 1
PREDNISONE 236 201 12 33
FUROSEMIDE 210 205 13 8
MELOXICAM 208 175 14 27
CARVEDILOL 208 163 14 24
METOPROLOL SUCCINATE 195 175 16 20
GABAPENTIN 194 139 17 13
PRAVASTATIN SODIUM 170 153 18 7
GLYBURIDE-METFORMIN HCL 170 149 R 18 88
METFORMIN HCL 169 137 20 9
TRAMADOL HCL 167 138 21 16
DONEPEZIL HCL 166 166 22 32
CRESTOR 155 151 23 23
TAMSULOSIN HCL 149 121 24 34
NEXIUM 148 110 25 19
FENOFIBRATE 144 109 26 55
HYDROCHLOROTHIAZIDE 144 134 26 12
CITALOPRAM HBR 124 112 28 22
PAROXETINE HCL 112 108 29 73
WARFARIN SODIUM 110 95 30 21
LOSARTAN POTASSIUM 96 92 31 26
SERTRALINE HCL 95 81 32 25
ATENOLOL 92 78 33 28
POTASSIUM CHLORIDE 86 79 34 18
ALENDRONATE SODIUM 77 70 35 40
LYRICA 75 59 36 74
FLUOXETINE HCL 75 54 36 52
DIOVAN 70 70 38 37
AZITHROMYCIN 69 59 39 39
KLOR-CON M20 65 64 40 59
RANITIDINE HCL 64 51 41 17
GLIPIZIDE 63 61 42 56
TRAZODONE HCL 63 43 42 38
LANTUS 61 61 44 66
GLIPIZIDE ER 61 61 44 77
CEFDINIR 60 54 46 172
BENAZEPRIL HCL 60 58 46 41
ALLOPURINOL 59 59 48 30
CYMBALTA 59 55 48 44
CLOPIDOGREL 56 56 50 31
SYNTHROID 55 54 51 61
AMLODIPINE BESYLATE-BENAZEPRIL 54 43 52 42
NAMENDA 51 51 53 43
PEN NEEDLE 50 40 54 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.